Teneligliptin 20mg, Pioglitazone 15mg & Extended Release Metformin Hydrochloride 500 . .. . .

Teneligold PM 500
Teneligliptin 20mg, Pioglitazone 15mg & Extended Release Metformin Hydrochloride 500

The combination of Teneligliptin (20mg), Pioglitazone (15mg), and Extended-Release Metformin Hydrochloride (500mg) is a medication used in the management of type 2 diabetes. Let's look at each component:

Teneligliptin (20mg):

Class: Teneligliptin belongs to the class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Mechanism of Action: It works by inhibiting the enzyme DPP-4, which increases the levels of incretin hormones. Incretins help regulate blood sugar levels by increasing insulin release and reducing the amount of glucose produced by the liver.
Indications: Teneligliptin is used to improve glycemic control in adults with type 2 diabetes mellitus.
Pioglitazone (15mg):

Class: Pioglitazone is a thiazolidinedione (TZD).
Mechanism of Action: It primarily works by improving insulin sensitivity in peripheral tissues, such as muscle and fat, and by reducing glucose production in the liver.
Indications: Pioglitazone is used to lower blood sugar levels in individuals with type 2 diabetes.
Extended-Release Metformin Hydrochloride (500mg):

Class: Metformin is a biguanide.
Mechanism of Action: It reduces glucose production in the liver and improves insulin sensitivity in peripheral tissues, leading to lower blood sugar levels.
Indications: Metformin is commonly used to treat type 2 diabetes and is often included in combination therapies.
Combination:

The combination of Teneligliptin, Pioglitazone, and Extended-Release Metformin is designed to address different aspects of glucose regulation. Teneligliptin increases incretin levels, Pioglitazone improves insulin sensitivity, and Metformin reduces glucose production and improves insulin action.
Important Considerations:

Prescription and Dosage: The specific dosage and formulation of the combination medication will be determined by the healthcare provider based on individual patient factors and the response to treatment.
Blood Glucose Monitoring: Regular monitoring of blood glucose levels is essential to assess the effectiveness of the treatment.
Adherence to Treatment: It's crucial to take the combination medication exactly as prescribed to achieve optimal results.
Potential Side Effects:

Each component can have its own set of side effects. Common side effects may include gastrointestinal symptoms such as nausea, diarrhea, or stomach discomfort.
Severe side effects are rare but should be reported to a healthcare provider promptly.
Precautions:

Inform your healthcare provider about any existing medical conditions, allergies, or medications you may be taking.
Regular follow-ups with the healthcare provider are important to assess the response to treatment and manage any potential side effects.
Always follow the guidance of your healthcare provider regarding the use of this combination medication. If you have specific questions or concerns about your diabetes treatment, it's advisable to discuss them with your healthcare provider for personalized advice.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
Order now:
https://www.sterisonline.com/product/teneligold-pm-500-134300